Adar1 Capital Management, LLC Cassava Sciences Inc Transaction History

Adar1 Capital Management, LLC

  • $1.06 Trillion
  • Q3 2025

A detailed history of Adar1 Capital Management, LLC transactions in Cassava Sciences Inc stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 81,000 shares of SAVA stock, worth $223,559. This represents 0.02% of its overall portfolio holdings.

Number of Shares
81,000
Holding current value
$223,559
% of portfolio
0.02%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$1.85 - $3.41 $149,850 - $276,210
81,000 New
81,000 $236 Million

About CASSAVA SCIENCES INC

SAVA Quotes by TradingView
  • Ticker SAVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,097,900
  • Market Cap $111M
  • Description
  • Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...
More about SAVA
Track This Portfolio

Track Adar1 Capital Management, LLC Portfolio

Follow Adar1 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adar1 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adar1 Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email